# The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects

> **NCT04008901** · PHASE3 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 92 (actual)

## Conditions studied

- Functional Dyspepsia
- Irritable Bowel Syndrome

## Interventions

- **DRUG:** BST-104 (Lonicera Flos Extract)
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04008901
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2018-07-02
- **Final completion:** 2018-11-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008901, "The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04008901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*